LATEST NEWS

Early lung cancer found using EarlyCDT-Lung

An early lung cancer was detected in a woman with no symptoms using the EarlyCDT-Lung test as part of a Scottish study.

The woman said: “If it wasn’t for the study it would have been too late. It saved my life.

CLICK HERE FOR LINKS TO PRESS ARTICLES

NEW TEST PROVIDER - LIFESCAN

Lifescan have launched the EarlyCDT-Lung blood test as part of their Lung Check. If patients have a Moderate or High EarlyCDT-Lung test result, they will be offered a follow up CT scan, free of charge.

CLICK HERE FOR INFORMATION

85% of lung cancers are diagnosed late stage | EarlyCDT-Lung

85% of lung cancers are diagnosed late stage

Find lung cancer before symptoms appear. EarlyCDT-Lung combined with CT can help.

Learn More
Autoantibodies are detectible up to 5 years before a tumor is visible.

EarlyCDT-Lung:

Panel of autoantibodies to aid in early lung cancer detection

Learn More

When Found Early Stage, 5 Year Survival Rate More Than Triples

Recent NLST Trial further shows 20% mortality improvement. EarlyCDT-Lung can reduce false positives associated with CT.

Learn More

EarlyCDT-Lung is a simple blood test that:

  • Has 5 times better Positive Predictive Value (PPV) than CT
  • Has 7 times fewer false positives than CT
  • Detects all types and all stages of lung cancer, including at the earliest stages
  • Positive test implies 5x risk of cancer
Learn More

Doctors

Your Challenge with Lung Cancer

How to identify the relatively small percentage of lung cancers (5-50 depending on the level of risk), per 1,000, that are present in your high-risk patient population. More….

Use of EarlyCDT-Lung:

  • As a risk assessment test to aid in the early detection of lung cancer in your high-risk patients; most notably long-term smokers and ex-smokers.
  • A new tool to risk stratify pulmonary nodules.

Patients

Brief Overview

EarlyCDT-Lung is a simple blood test which is ordered by a GP, or other suitably qualified medical professional, to aid in the risk assessment and early detection of lung cancer. More…

Risk Assessment:
Subscribe by Email
Your email: